Fluidic Analytics

Fluidic Analytics Limited is a biotechnology company founded in 2013 as a spin-out from the University of Cambridge. The company specializes in biophysical technologies for analyzing protein interactions, which supports advancements in therapeutics, diagnostics, and vaccines. Co-founded by Andrew Lynn and Professor Tuomas Knowles, Fluidic Analytics has developed the Fluidity One platform, a microfluidic system that allows for quantitative characterization of protein interactions in complex samples. The Fluidity One platform includes products like Fluidity One-W, One-W Serum, and One-M, designed for protein analysis in various biological fluids. The technology employs Microfluidic Diffusional Sizing (MDS) to study disease mechanisms and antibody affinity profiling, aiding researchers and clinicians in understanding proteins' roles in diseases. The company serves a diverse range of applications across research, clinical, and medical fields, providing accessible instrumentation and software solutions to enhance disease diagnosis and treatment development.